ANNX+40.19%20.0%
BHVN-11.19%20.0%
DNLI+35.76%20.0%
KYMR+91.77%20.0%
VRTX+24.66%20.0%
As of Oct 2, 2026, 9:55 PM ET
Rare Diseases '25: CNS/Neuro Constituents
Annexon, Inc.ANNX | 20.0% | 1.70% | 4.31% | -11.56% | 5.83% | -13.15% | -22.14% | 122.45% | 40.19% | -32.53% | -77.64% | $686.5M |
Biohaven Ltd.BHVN | 20.0% | -2.05% | -7.24% | -12.21% | 4.83% | 22.01% | 19.57% | -41.83% | -11.19% | -72.41% | 76.30% | $1.94B |
Denali Therapeutics Inc.DNLI | 20.0% | -2.58% | -4.47% | -9.69% | 0.51% | 24.98% | -2.57% | 50.18% | 35.76% | -29.13% | -60.77% | $3.17B |
Kymera Therapeutics, Inc.KYMR | 20.0% | -2.48% | -12.02% | -9.47% | -2.48% | 38.02% | 17.56% | 307.40% | 91.77% | 147.39% | 78.33% | $8.83B |
Vertex Pharmaceuticals IncorporatedVRTX | 20.0% | -0.42% | -1.03% | -8.45% | 0.58% | 12.43% | 2.59% | 5.42% | 24.66% | 11.28% | 179.86% | $128.10B |
| Theme return | — | -1.17% | -4.09% | -10.33% | 1.09% | 23.59% | 6.78% | 85.58% | 49.83% | 4.15% | 105.70% | — |
| Average | 20.0% | -1.17% | -4.09% | -10.28% | 1.85% | 16.86% | 3.00% | 88.72% | 36.24% | 4.92% | 39.22% | $28.55B |
| Median | 20.0% | -2.05% | -4.47% | -9.69% | 0.58% | 22.01% | 2.59% | 50.18% | 35.76% | -29.13% | 76.30% | $3.17B |
| Std Dev | 0.0% | 1.63% | 5.53% | 1.39% | 3.06% | 17.09% | 15.16% | 122.01% | 33.12% | 76.00% | 96.27% | $49.86B |
| Min | 20.0% | -2.58% | -12.02% | -12.21% | -2.48% | -13.15% | -22.14% | -41.83% | -11.19% | -72.41% | -77.64% | $686.5M |
| Max | 20.0% | 1.70% | 4.31% | -8.45% | 5.83% | 38.02% | 19.57% | 307.40% | 91.77% | 147.39% | 179.86% | $128.10B |
| % Positive Tickers | 20.00% | 20.00% | 0.00% | 80.00% | 80.00% | 60.00% | 80.00% | 80.00% | 40.00% | 60.00% |
Default: Wgt ↓ · Click headers to sort · Shift+click secondaryWgt ↓ · Scroll right · Tap headers to sort